Abstract P201 Table 1

Comparison of characteristics for patients with positive and negative samples

Pneumocystis Jiroveccii result
NumberNegativePositiveSig.
937NS
Demographics
Male gender, n (%)52 (55.9)4 (57.1)NS
Mean age (yr), SD33.8 ± 11.132.5 ± 10.1NS
Spirometry and laboratory results
Mean FEV1 (% predicted), SD56 ± 20.167 ± 29.5NS
Mean BMI (kg/m2)22.1 ± 3.222.2 ± 2.1NS
WCC (x109/L) at recruitment9.3 ± 3.19.3 ± 2.8NS
CRP (mg/L) at recruitment13.0 ± 16.87.9 ± 7.5NS
Chronic colonisation, n (%)
Pseudomonas aeruginosa 59 (63.4)5 (71.4)NS
Staphylococcus aureus 24 (25.8)1 (14.3)NS
B. cepacia complex14 (10.3)2 (28.6)NS
Achromobacter xylosoxidans 6 (6.4)0NS
Ralstonia species5 (5.4)0NS
NTM5 (5.4)1 (14.3)NS
Aspergillus fumigatus 4 (4.3)1 (14.3)NS
Pandoraea species1 (1.1)1 (14.3)NS
MRSA1 (1.1)1 (14.3)NS
Treatment, n (%)
Inhaled antibiotics72 (77.4)6 (85.7)NS
Inhaled steroids59 (63.4)6 (85.7)NS
Oral steroids (continuous)12 (12.9)1 (14.3)NS
Prophylactic macrolide77 (83.0)5 (71.4)NS
Azole therapy8 (8.6)0NS
Co-trimoxazole past 3 months32 (34.4)00.06
  • Key: SD = standard deviation, WCC = serum white cell count, B.cepacia complex = Burkholderia cepacia complex, NTM = Non-tuberculous mycobacteria, MRSA = Methicillin resistant Staphylococcus aureus, NS = not significant, p values <0.1 are shown.